Cresco Labs Finalizes Acquisition of Hope Heal Health

Cresco Labs (CSE:CL), has received change in ownership approval from the Massachusetts Cannabis Control Commission, and has thus finalized the acquisition of Hope Heal Health Inc.

Currently, Hope Heal Health owns a facility and dispensary in Fall River Massachusetts, and is fully functioning as a cannabis cultivator and manufacturer. The company also holds several state licenses, including a retail license, manufacturing license, as well as a cultivation license. Hope Heal Health also has the ability to procure two additional retail licenses in Massachusetts

In addition, Hope Heal Health has also recently been granted a recreational cannabis license for its dispensary, meaning that following the acquisition, the company can still sell cannabis to medical-use patients, but will also be catering to adult-use customers through Cresco’s several cannabis brands.

Now that the acquisition is complete, Cresco plans to distribute its branded products in the Massachusetts adult-use cannabis market. The company owns several brands, including Remedi, Cresco, and Mindy’s Edibles.

Cresco Labs is a United States based cannabis operator, and is currently trading at $7.31 on the CSE.


Information for this briefing was found via Sedar and Cresco Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Why Gold And Silver Stay High Even After Rate Cuts | Todd Bubba Horwitz

Recommended

TomaGold Confirms Presence Of Berrigan Deep Zone Following Geophysics

Antimony Resources Reports Massive Stibnite Mineralization Over 25 Metres At Marcus (West) Zone

Related News

Cresco Labs Receives Court Approval To Proceed With Columbia Care Acquisition

Cresco Labs (CSE: CL) is inching closer to finalizing its previously announced acquisition of Columbia...

Friday, July 15, 2022, 08:09:23 AM

Haywood Initiates Coverage On Cresco Labs With $14.00 Price Target

Last week, Haywood Securities initiated coverage on Cresco Labs (CSE: CL) with a C$14.00 price...

Wednesday, November 4, 2020, 01:59:00 PM

Cresco Labs Records Q3 Revenues of $215.5 Million, Impairs $290.9 Million In Assets

Cresco Labs (CSE: CL) reported its third quarter financial results this morning, reporting marginal revenue...

Thursday, November 11, 2021, 07:54:22 AM

Cresco Labs: Canaccord Maintains Price Target Following FY2020 Results

Last week, Cresco Labs (CSE: CL) reported their fourth quarter and full-year 2020 financial results....

Monday, March 29, 2021, 11:44:00 AM

Cresco Labs Finally Closes Acquisition of Origin House

The acquisition of Origin House (CSE: OH) by Cresco Labs (CSE CL) has finally closed...

Wednesday, January 8, 2020, 09:53:28 AM